Skip to main content

Table 3 Total expenditures from public budget on the reimbursement of oncology orphan drugs

From: Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe

Country

2014 (million euro)

2015 (million euro)

2016 (million euro)

Bulgaria

11

13

16

Croatia

9

11

15

Czechia

27

36

44

Estonia

4

5

5

Hungary

18

27

41

Latvia

1

1

1

Lithuania

2

3

4

Poland

57

67

75

Romania

24

27

31

Slovakia

23

27

33

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172